Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dermatopharmacokinetic Trial of LEO 90100 Foam

NCT03476746 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT03476746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03476746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dermatopharmacokinetic Trial of LEO 90100 Foam
Lead sponsor
LEO Pharma
Phase
Phase 1
Overall status
Completed
Start date
March 20, 2018
Completion date
July 1, 2018
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy